News GenoScreen Expertise
Meet us at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
GenoScreen will be present at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) on April 13 in Amsterdam.
A major advance in the fight against multidrug-resistant tuberculosis
Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.
Meet us at the POLEPHARMA Microbiomics Days
GenoScreen will participate in the 1st edition of the POLEPHARMA Microbiomics Days which will be organized on April 9 & 10 at the HEALTH UFR of the University of Rouen.
Discover Deeplex-MycTB
Discover Deeplex-MycTB, a next-generation molecular analysis solution that allows, in a single test,
- to identify the mycobacteria of the M. tuberculosis complex causing tuberculosis,
- to predict their resistance to multiple antibiotics of first and second intent
- and to type them for epidemiological surveillance purposes.
Metabiote® protocol is now GCLP compliant
Metabiote®, the reference protocol in targeted metagenomics developed by GenoScreen, is now GCLP compliant.